BioCryst to Present at Upcoming Investor Conferences
22 Agosto 2024 - 1:00PM
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced
that the company plans to present at the following conferences:
- 2024 Wells Fargo Healthcare
Conference in Boston on Thursday, September 5, 2024, at 1:30 p.m.
ET.
- H.C. Wainwright 26th Annual Global
Investment Conference in New York on Monday, September 9, 2024, at
9:00 a.m. ET.
- 2024 Cantor Global Healthcare
Conference in New York on Thursday, September 19, 2024, at 12:45
p.m. ET.
Links to the live audio webcasts and replays of
the presentations may be accessed in the Investors & Media
section of BioCryst’s website at http://www.biocryst.com.
About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals is a global biotechnology company with a
deep commitment to improving the lives of people living with
complement-mediated and other rare diseases. BioCryst leverages its
expertise in structure-guided drug design to develop first-in-class
or best-in-class oral small-molecule and protein therapeutics to
target difficult-to-treat diseases. BioCryst has commercialized
ORLADEYO® (berotralstat), the first oral, once-daily plasma
kallikrein inhibitor, and is advancing a pipeline of small-molecule
and protein therapies. For more information, please visit
www.biocryst.com or follow us on LinkedIn.
BCRXW
Contact:John Bluth+1 919 859
7910jbluth@biocryst.com
Grafico Azioni BioCryst Pharmaceuticals (NASDAQ:BCRX)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni BioCryst Pharmaceuticals (NASDAQ:BCRX)
Storico
Da Dic 2023 a Dic 2024
